Cencora
COR • NYSE
Cencora is a medical - distribution company in the healthcare sector trading on NYSE, led by CEO Robert Mauch, with a market cap of $70.2B.
CEORobert Mauch
Market Cap$70.2B
Medical - Distribution
Healthcare
Employees46.0K
Websitecencora.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Cencora
Date
Wednesday, May 6, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q2 2026
EPS Estimate
$4.77
Revenue Estimate
$81.1B
Earnings History
Past 12 earnings reports for Cencora
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q1 2026 | $4.08Est: $4.05 | +0.7% | $85.9BEst: $86.1B | -0.2% |  10-Q |
| Nov 5, 2025 | Q4 2025 | $3.84Est: $3.79 | +1.3% | $83.7BEst: $83.3B | +0.5% | 10-K |
| Aug 6, 2025 | Q3 2025 | $4.00Est: $3.81 | +5.0% | $80.7BEst: $80.2B | +0.6% | 10-Q |
| May 7, 2025 | Q2 2025 | $4.42Est: $4.10 | +7.8% | $75.5BEst: $75.8B | -0.5% | 10-Q |
| Feb 5, 2025 | Q1 2025 | $3.73Est: $3.52 | +6.0% | $81.5BEst: $78.2B | +4.2% | 10-Q |
| Nov 6, 2024 | Q4 2024 | $3.34Est: $3.22 | +3.7% | $79.1BEst: $77.7B | +1.8% | 10-K |
| Jul 31, 2024 | Q3 2024 | $3.34Est: $3.22 | +3.7% | $74.2BEst: $73.5B | +1.0% | 10-Q |
| May 1, 2024 | Q2 2024 | $3.80Est: $3.69 | +3.0% | $68.4BEst: $70.7B | -3.2% | 10-Q |
| Jan 31, 2024 | Q1 2024 | $3.28Est: $2.89 | +13.5% | $72.3BEst: $69.2B | +4.5% | 10-Q |
| Nov 2, 2023 | Q4 2023 | $2.86 | — | $68.9BEst: $66.0B | +4.4% | — |
| Aug 2, 2023 | Q3 2023 | $2.92Est: $2.83 | +3.2% | $66.9BEst: $63.4B | +5.6% | 10-Q |
| May 2, 2023 | Q2 2023 | $3.50Est: $3.29 | +6.4% | $63.5BEst: $60.4B | +5.1% | — |